Competitive athletes with cardiovascular disease - The case of Nicholas Knapp

New England Journal of Medicine

Volumn 339, Issue 22, 1998, Pages 1632-1635

  Maron, Barry J ^a   Mitten, Matthew J ^b   Quandt, Eric F ^c   Zipes, Douglas P ^d  

^a MINNEAPOLIS HEART INSTITUTE FOUNDATION   (United States)

^b South Texas College of Law   (United States)

^c Kelley Drye and Warren   (United States)

^d INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ATHLETE; CARDIOVASCULAR DISEASE; COURT; HUMAN; LEGAL ASPECT; PRIORITY JOURNAL; UNIVERSITY;

ADOLESCENT; BASKETBALL; CARDIOMYOPATHY, HYPERTROPHIC; CARDIOVASCULAR DISEASES; DEFIBRILLATORS, IMPLANTABLE; DISABLED PERSONS; EQUIPMENT FAILURE; HEART ARREST; HUMANS; MALE; SPORTS; UNITED STATES;

EID: 0032569882     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199811263392211     Document Type: Article

References (27)

1. Maron BJ, Shirani J, Poliac LC, Mathenge R, Roberts WC, Mueller FO. Sudden death in young competitive athletes: clinical, demographic, and pathological profiles. JAMA 1996;276:199-204.
2. Liberthson RR. Sudden death from cardiac causes in children and young adults. N Engl J Med 1996;334:1039-44.
3. Van Camp SP, Bloor CM, Mueller FO, Cantu RC, Olson HG. Non-traumatic sports death in high school and college athletes. Med Sci Sports Exerc 1995;27:641-7.
4. Burke AP, Farb A, Virmani R, Goodin J, Smialek JE. Sports-related and non-sports-related sudden cardiac death in young adults. Am Heart J 1991; 121:568-75.
5. Maron BJ, Roberts WC, McAllister HA, Rosing DR, Epstein SE. Sudden death in young athletes. Circulation 1980;62:218-29.
6. Maron BJ. Sudden death in young athletes - lessons from the Hank Gathers affair. N Engl J Med 1993;329:55-7.
7. Maron BJ, Mitchell JH, eds. 26th Bethesda Conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities, January 6 and 7, 1994. J Am Coll Cardiol 1994;24: 845-99.
8. Mitten MJ. Enhanced risk of harm to one's self as a justification for exclusion from athletics. Marq Sports L J 1998;8:189-223.
9. Jones CJ. College athletes: illness or injury and the decision to return to play. Buff L Rev 1992;40:113-215.
10. Mitten MJ, Maron BJ. Legal considerations that affect medical eligibility for competitive athletes with cardiovascular abnormalities and acceptance of Bethesda Conference recommendations. J Am Coll Cardiol 1994; 24:861-3.
11. 1997-98 NCAA sports medicine handbook. Overland Park, Kans.: National Collegiate Athletic Association, 1997:14.
12. Knapp v. Northwestern University. 101 F.3d 473 (7th Cir. 1996), cert. denied, 117 S.Ct. 2454 (1997).
13. Mirowski M, Reid PR, Mower MM, et al. Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. N Engl J Med 1980;303:322-4.
14. Zipes DP, Roberts D. Results of the international study of the implantable pacemaker cardioverter-defibrillator: a comparison of epicardial and endocardial lead systems. Circulation 1995;92:59-65.
15. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997;337:1576-83.
16. Spirito P, Maron BJ, Bonow RO, Epstein SE. Severe functional limitation in patients with hypertrophic cardiomyopathy and only mild localized left ventricular hypertrophy. J Am Coll Cardiol 1986;8:537-44.
17. Klues HG, Schiffers A, Maron BJ. Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients. J Am Coll Cardiol 1995;26:1699-708.
18. Maron BJ, Wolfson JK, Ciró E, Spirito P. Relation of electrocardiographic abnormalities and patterns of left ventricular hypertrophy identified by two-dimensional echocardiography in patients with hypertrophic cardiomyopathy. Am J Cardiol 1983;51:189-94.
19. 29 USCA §§ 701-796i (West 1985;1998 Supp.).
20. Zipes DP, Garson A Jr. Task Force 6: arrhythmias: 26th Bethesda Conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. J Am Coll Cardiol 1994;24: 892-9.
21. Fan W, Peter CT. Survival and incidence of appropriate shocks in impiantable cardioverter defibrillator recipients who have no detectable structural heart disease. Am J Cardiol 1994;74:687-90.
22. Benson DW Jr, Benditt DG, Anderson RW, et al. Cardiac arrest in young, ostensibly healthy patients: clinical, hemodynamic, and electrophysiologic findings. Am J Cardiol 1983;52:65-9.
23. Bragdon v. Abbott 118 S.Ct. 2196 (1998).
24. 42 USCA §§ 12101-12213 (West 1995;1998 Supp.).
25. Mitten MJ. Amateur athletes with handicaps and physical abnormalities: who makes the participation decision? U Nebr L Rev 1992;71(4):987-1032.
26. Martin v. PGA Tour, Inc., 994 F Supp 1242 (D. Ore. 1998).
27. Tye L. Medical lessons from Lewis' death. Boston Globe. August 1, 1993:49.